Physicians' Academy for Cardiovascular Education

Lipid management

Slides (presentation) - Apr. 7, 2011

Cholesterol Lowering and CV Risk: Meta-analyses - 8 slides

The second cycle of the Cholesterol Treatment Trialists’ (CTT) Collaboration consisted of 2 parts: a meta-analysis of more versus less intensive statin therapy and an updating of the first cycle meta-analysis of statin versus control that added 7 more trials.




Preview slide presentation - click on pictures


Cholesterol Lowering and CV Risk: Meta-analyses
On-Treatment LDL and CHD Events in Statin Trials
Second Cycle of the CTT Meta-analysis: Proportional Effects on Major Vascular Events Per Mmol/L LDL-C Reduction
Second Cycle of the CTT Meta-analysis: More vs Less Statin—Proportional Effects on Major Vascular Events Per Mmol/L LDL-C Reduction
Second Cycle of the CTT Meta-analysis: Statin vs Control—Proportional Effects on Major Vascular Events Per Mmol/L LDL-C Reduction
Meta-analysis of Statin Trials and Fatal and Nonfatal Stroke
Meta-analysis of Statin Trials and Stroke Mortality
Stroke Risk and LDL Lowering in Statin Trials

Share this page with your colleagues and friends: